$0.77
0.18%
Nasdaq, Oct 05, 10:46 am EDT. Market open.
ISIN
US74365N1037
Symbol
PTIX

Protagenic Therapeutics Inc Stock price

$0.77
-0.28 26.30% 1M
+0.24 46.02% 6M
-0.66 45.85% YTD
-0.66 45.85% 1Y
-11.79 93.84% 3Y
-49.21 98.45% 5Y
+0.76 5,427.86% 10Y
-26,054,604.54 100.00% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
-0.01 0.78%
ISIN
US74365N1037
Symbol
PTIX
Industry

Is Protagenic Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$1.4m
Enterprise Value
$830.0k
Net debt
positive
Cash
$570.0k
Shares outstanding
1.8m
Valuation
P/E
0.3
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
negative | negative
P/B
0.8
Financial Health
Equity Ratio
71.7%
Return on Equity
52.2%
ROCE
-180.4%
ROIC
-262.2%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$490.0k | -
SBC as % of FCF
-
SBC Growth 1Y
-43.0%
Share Count Growth 1Y
-2.2%
Shareholder Yield
2.2%
Financials
Revenue | estimate
$0.0 | -
EBITDA
$-3.1m
EBIT
$-3.1m
Net Income
$5.5m
Free Cash Flow | ex SBC
$-2.6m | $-3.1m
Growth
Revenue | estimate
- | -
EBITDA
48.3%
EBIT
48.1%
Net Income
162.8%
Free Cash Flow
20.4%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$3.0
FCF per Share
$-1.4
Short interest
3.3%
Employees
3
Rev per Employee
$0.0

Protagenic Therapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Protagenic Therapeutics Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Protagenic Therapeutics Inc forecast:

Buy
86%
Hold
14%

Financial data from Protagenic Therapeutics Inc

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 2.43 2.43
32% 32%
-
- Research and Development Expense 0.69 0.69
73% 73%
-
-3.08 -3.08
48% 48%
-
- Depreciation and Amortization 0.05 0.05
0% 0%
-
EBIT (Operating Income) EBIT -3.12 -3.12
48% 48%
-
Net Profit 5.46 5.46
163% 163%
-

In millions USD.

Don't miss a Thing! We will send you all news about Protagenic Therapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Protagenic Therapeutics Inc Stock News

Neutral
Accesswire
●
about 2 months ago
FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical packages; IND submission remains on track for the fourth quarter of 2026 NEW YORK, NY / ACCESS Newswire / August 20, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based treatments for stress-related neu...
Neutral
Accesswire
●
3 months ago
As published in Behavioural Pharmacology, two days of PT00114 treatment reduced corticosterone levels and attenuated anxiety-like behavior in chronically stressed rats; a known CRF₁ receptor antagonist did not show activity in the same model. NEW YORK, NY / ACCESS Newswire / June 30, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company focused on novel n...
Neutral
Accesswire
●
5 months ago
NEW YORK, NY / ACCESS Newswire / May 19, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based therapies for stress-related neuropsychiatric disorders, today announced two strategic engagements to support the advancement of its lead candidate, PT00114. The Company has engaged Floyd Regulatory Strategic Consulting, led by reg...
More Protagenic Therapeutics Inc News

Company Profile

Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.

Head office United States
Employees 3
Founded 1994
Website protagenic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today